(Q36881873)

16 August 2017

title

Relevance of tumoral folylpolyglutamate synthetase and reduced folates for optimal 5-fluorouracil efficacy: experimental data (English)

1 reference

16 August 2017

1 reference

Chéradame S

1

1 reference

16 August 2017

Etienne MC

2

1 reference

16 August 2017

Chazal M

3

1 reference

16 August 2017

Guillot T

4

1 reference

16 August 2017

Fischel JL

5

1 reference

16 August 2017

Formento P

6

1 reference

16 August 2017

Milano G

7

1 reference

16 August 2017

publication date

1 May 1997

1 reference

European Journal of Cancer

16 August 2017

published in

1 reference

16 August 2017

volume

33

1 reference

16 August 2017

issue

6

1 reference

16 August 2017

page(s)

950-959

1 reference

Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900028-2

7 January 2021

Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900028-2

7 January 2021

Clinical relevance of biochemical modulation of 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900028-2

7 January 2021

Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900028-2

7 January 2021

A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900028-2

7 January 2021

A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900028-2

7 January 2021

The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900028-2

7 January 2021

Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900028-2

7 January 2021

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900028-2

7 January 2021

Sequential methotrexate, 5-fluorouracil (5-FU), and high dose leucovorin versus 5-FU and high dose leucovorin versus 5-FU alone for advanced colorectal cancer. A multi-institutional randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900028-2

7 January 2021

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900028-2

7 January 2021

Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900028-2

7 January 2021

Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900028-2

7 January 2021

Effect of 5,10-methylenetetrahydrofolate on the dissociation of 5-fluoro-2'-deoxyuridylate from thymidylate synthetase: evidence for an ordered mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900028-2

7 January 2021

Effect of polyglutamylation of 5,10-methylenetetrahydrofolate on the binding of 5-fluoro-2'-deoxyuridylate to thymidylate synthase purified from a human colon adenocarcinoma xenograft

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900028-2

7 January 2021

Wide range for optimal concentration of folinic acid in fluorouracil modulation--experimental data on human tumour cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900028-2

7 January 2021

Phase II trial of cisplatin, fluorouracil, and pure folinic acid for locally advanced head and neck cancer: a pharmacokinetic and clinical survey

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900028-2

7 January 2021

Lack of interference by the unnatural isomer of 5-formyltetrahydrofolate with the effects of the natural isomer in leucovorin preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900028-2

7 January 2021

Factors that influence the therapeutic activity of 5-fluorouracil [6RS]leucovorin combinations in colon adenocarcinoma xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900028-2

7 January 2021

Leucovorin and folic acid regimens for selective expansion of murine 5,10-methylenetetrahydrofolate pools

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900028-2

7 January 2021

Changes in folate concentration in Yoshida sarcoma after administration of leucovorin or cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900028-2

7 January 2021

Plasma and tumor tissue pharmacology of high-dose intravenous leucovorin calcium in combination with fluorouracil in patients with advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900028-2

7 January 2021

Ternary complex formation and reduced folate in surgical specimens of human adenocarcinoma tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900028-2

7 January 2021

10.1016/S0959-8049(97)00028-2

Identifiers

DOI

1 reference

16 August 2017

1 reference